887589-25-5 Usage
Uses
Used in Pharmaceutical Industry:
2-Hydrazinoisonicotinic acid is used as an antimicrobial and antifungal agent for its potential to inhibit the growth of various bacterial and fungal strains. Its activity against these microorganisms makes it a promising candidate for the development of new drugs to combat infections.
Used in Organic Synthesis:
2-Hydrazinoisonicotinic acid is used as a building block in organic synthesis for the preparation of various pharmaceutical compounds. Its unique chemical structure allows it to be a versatile component in the creation of new molecules with potential therapeutic applications.
Used in Antimicrobial Research:
In the field of antimicrobial research, 2-Hydrazinoisonicotinic acid is used as a subject of study to understand its mechanism of action and to explore its potential as a lead compound for the development of new antimicrobial drugs. Its ability to inhibit dihydropteroate synthase makes it a valuable tool in the fight against antibiotic-resistant bacteria.
Used in Antifungal Research:
Similarly, in antifungal research, 2-Hydrazinoisonicotinic acid is utilized to investigate its efficacy against fungal infections. Its potential as an antifungal agent could lead to the development of new treatments for various fungal diseases, improving patient outcomes and addressing the need for new antifungal therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 887589-25-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,5,8 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 887589-25:
(8*8)+(7*8)+(6*7)+(5*5)+(4*8)+(3*9)+(2*2)+(1*5)=255
255 % 10 = 5
So 887589-25-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3O2/c7-9-5-3-4(6(10)11)1-2-8-5/h1-3H,7H2,(H,8,9)(H,10,11)
887589-25-5Relevant academic research and scientific papers
HISTONE DEMETHYLASE INHIBITORS
-
Paragraph 00162; 00163, (2014/06/24)
Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
